Infrared Sciences Corp. Exploring Strategic Alternatives Also Announces Completion of a Clinical Study of the Sentinel BreastScan? Early Breast Cancer
Infrared Sciences Corp., manufacturer of the Sentinel BreastScan, is exploring strategic alternatives including possible sale of the company. ISC also announced that it has completed the clinical study of the Sentinel at Cornell Weill Medical College, has presented the study results at the American Society of Breast Surgeons conference earlier this month, and is pending publication of the study manuscript in the American Journal of Surgery.

After 50 Year Wait, Quick and Easy Breakthrough Test Gauges Breast Cancer Risk
According to Dana Shapiro, Director of Operations - OB/GYN Division at Acupath Laboratories, Inc, a pathology and cancer genetics laboratory, "This is an exciting breakthrough that could lead to earlier detection. Like the cervical Pap test, the HALO Breast Pap Test can identify abnormal cells years before a larger, potentially cancerous lesion might develop. Because of that, this simple test is key to improving breast cancer outcomes. The test can be done in your doctor's office as part of your annual well-woman visit."

UCSF Researchers Use New Tools to Move in on Cancer Susceptibility Genes
UCSF (http://www.ucsf.edu/) researchers have used a new strategy to study inherited susceptibility for skin cancer in mice. In the process, they have identified a network of genes that may play a key role in controlling this susceptibility. The technique, the scientists say, could be used to identify such genes in human cancers.